Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 3Other hematologic neoplasm 3Head & Neck 2CNS 2Tumor-Agnostic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Head and Neck Neoplasms 2

Interventions

Cisplatin 144Radiotherapy 71Fluorouracil 50Radiotherapy, Intensity-Modulated 45Docetaxel 39Gemcitabine 38Cetuximab 38Carboplatin 31pembrolizumab 25Capecitabine 22Drug Therapy 17toripalimab 14Paclitaxel 14camrelizumab 10Surgical Procedures, Operative 10Nivolumab 10Chemoradiotherapy 10nimotuzumab 9Radiation 9Neoadjuvant Therapy 8Methotrexate 8Magnetic Resonance Spectroscopy 8Chemotherapy, Adjuvant 8nedaplatin 7Thyrotropin Alfa 7Platinum 7tislelizumab 6spartalizumab 6Standard of Care 6Specimen Handling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Tranexamic Acid × Head & Neck × Clear all
NCT00147862 2007-02-07

Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?

Tata Memorial Hospital

Phase 3 Completed
240 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00308880 2006-03-30

Tranexamic Acid and Head and Neck Surgery Patients

Taichung Veterans General Hospital

Phase 3 Unknown
80 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡